Research Project · Health
Neuroimaging and CSF Biomarker Program
Alzheimer's Drug Discovery Foundationwww.alzdiscovery.org (opens in a new tab)Catalog updated
- Amount
- $600,000
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
The Alzheimer's Drug Discovery Foundation (ADDF) offers the Neuroimaging and CSF Biomarker Program to advance the development and validation of biomarkers for Alzheimer's disease and related dementias, focusing on neuroimaging and CSF biomarkers. This grant supports research on novel PET ligands, CSF biomarkers, MRI approaches, and functional activity measures, with a priority on targets like neuroinflammation, synaptic integrity, autophagy, and TDP-43.
Applicants must demonstrate novelty, biological plausibility, and a clear path to clinical translation, with a focus on biomarkers addressing clinical needs and potential for commercialization. Eligible applicants include global researchers and clinicians from academic medical centers, universities, nonprofits, and biotechnology companies, with industry partnerships encouraged. Funding of up to $600,000 is available for one year, with potential for follow-on support.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 50 or more similar programs in full.
Ask for a demo of this program The form opens already filled in.